Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment

Lieke van Montfort, Caroline M. Loos, Monique Anten, Rob L. H. Jansen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1112-1115
Number of pages4
JournalCase Reports in Oncology
Volume10
Issue number3
DOIs
Publication statusPublished - 2017

Keywords

  • Melanoma
  • Immunotherapy
  • Side effects
  • Neuro-oncology tumor necrosis factor
  • CTLA-4 antigen
  • Ipilimumab
  • Herpes simplex encephalitis
  • SIMPLEX ENCEPHALITIS
  • MELANOMA

Cite this